Clinical trials are essential for advancing medical knowledge and developing new treatments, especially for rare diseases where options may be limited.
MitoCanada believes in the power of research. Clinical trials are studies conducted to acquire important data. They are essential to the discovery and advancement of medicine and medical knowledge.
When you share your real-life experiences by participating in a clinical trial, you are supporting the process of developing medicines that have the potential to impact patient care and quality of life. Participation in a clinical trial is voluntary and can offer many benefits, but there may also be risks. When deciding whether to join a clinical trial, it is important to be informed so you can make the best possible decision for you.
The following information aims to educate patients and their families about clinical trials, the importance of participation, and what to expect when considering joining a trial.
Phases of Clinical Trials
- Phase I: Tests the safety and dosage of a new treatment in a small group of healthy volunteers or patients.
- Phase II: Focuses on the efficacy and side effects of the treatment in a larger group of patients.
- Phase III: Compares the new treatment to the standard treatment in a large group of patients to confirm its effectiveness and monitor side effects.
- Phase IV: Conducted after a treatment is approved to gather additional information on its long-term effects and safety.
Participating in clinical trials is a personal decision that can have a significant impact on your health and the future of rare disease treatment. By understanding the process, benefits, and risks, you can make an informed choice about whether to participate. Remember, your involvement is a valuable contribution to medical research and the fight against rare diseases.
For more information or support, consider reaching out to patient advocacy groups like MitoCanada or discussing options with your healthcare provider.